The drawing in words
- THE LAW. 1978—the ESRD Networks are established: eighteen regional bodies, still here. [1]
- Public Law 99-509 §9335—the Network withhold: 50 cents per hemodialysis treatment, PD-adjusted, deducted from facility payment to fund the Networks; codified at SSA §1881(b)(7). The plate places this instrument by its public law number, not by a year: the year is not verified in the dataset. [2]
- 15 April 2008—the Conditions for Coverage are issued: 42 CFR Part 494, at 73 FR 20475. The spine everything else hangs from. [3]
- Trade Preferences Extension Act of 2015, sec. 808 opened certified ESRD facilities to acute kidney injury patients—effective 1 January 2017. The drawing carries the two-year gap between statute and effect. [4]
- 1 January 2021—21st Century Cures Act sec. 17006 opens Medicare Advantage enrollment to ESRD beneficiaries. The payer mix changes permanently. [5]
- THE SURVEY. October 2008—ESRD Program Interpretive Guidance v1.1, S&C-09-01: the V-tags, the checkpoints a surveyor cites. [6]
- 2016—the Emergency Preparedness rule adds §494.62 to Part 494, but it is scored under SOM Appendix Z as E-tags, not in the V-series: a condition inside the Conditions that the Conditions’ own tag system does not cover. Drawn as an ink rail, in force and outside the V-tags. [3 · 7]
- 2017—S&C 17-02: the Dialysis Facility Report becomes presurvey reading. The surveyor arrives having already read your data. [8]
- May 2026—QSO-26-09-ESRD relocates the ESRD guidance and survey protocol into State Operations Manual Appendix H, 420 pages. The guidance did not change; where it lives did. The plate draws that as a relocation chain, not a removal—both bands keep running. [9]
- THE MONEY. 2008—MIPPA 2008, SSA §1881(h) authorizes the first federal value-based purchasing program in Medicare. [10]
- 1 January 2025—oral-only phosphate binders enter the bundle via TDAPA. [11]
- 2026—the ESRD PPS base rate is $281.71 per treatment, up from $273.82: one case-mix-adjusted payment covering treatment, equipment, drugs, labs, supplies and capital. [11]
- TDAPA and TPNIES—two temporary side doors in a bundle designed to have none. TPNIES pays 65 percent of the MAC-determined price for two years; for CY2026 zero items are approved. The drawing shows that door open and empty. Start years not verified in the dataset. [17 · 18]
- THE MEASUREMENT. 24 June 2011—FDA Drug Safety Communication on ESA dosing in chronic kidney disease. The hemoglobin target consensus breaks. [12]
- 6 November 2014—the CY2015 final rule removes the hemoglobin-greater-than-12 QIP measure as topped out. Anemia stops being measured directly and starts being measured by its shadows: transfusions, hospitalizations, readmissions. A subtraction, drawn red—five decades of accumulation hold only three of them, and the load line counts two. [13]
- The QIP carries up to a 2 percent payment reduction; the PY2027 minimum Total Performance Score is 57. The performance year and the payment year are two different years, roughly two apart. [19 · 20]
- THE MODELS. 2021—the ETC (ESRD Treatment Choices) Model begins: a mandatory home-dialysis and transplant model. [14]
- 2022—the KCC (Kidney Care Choices) Model begins: a voluntary CKD/ESRD value-based model. Its KCF option ends 31 December 2025. [11 · 15]
- The CKCC options—Graduated, Professional, Global—are extended through 31 December 2027, and are still bearing load. [11]
- 1 July 2025 to 30 June 2031—the IOTA (Increasing Organ Transplant Access) Model runs. [16]
- 31 December 2025—the ETC Model is terminated early in the CY2026 final rule. With the KCF option, it is everything the load line loses in five decades. [11]
BRACKETED NUMBERS TRACE EACH LINE TO THE SOURCE LIST BELOW · EVERY SOURCE IS HELD IN THE REFERENCES LEDGER WITH ITS LOCATOR, ITS LAST-CHECKED DATE, AND HOW IT WAS VERIFIED